India gov’t seals deal for 300 mln Biological-E COVID-19 vaccine doses
India’s government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).
For more coronavirus news, visit our dedicated page.
The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement.
For all the latest headlines follow our Google News channel online or via the app.
Read more:
Mount Everest climbers struggle to return home amid Nepal COVID-19 travel curbs
India plans to more than triple COVID-19 vaccine shots per day in July, August